psyllium has been researched along with loperamide in 3 studies
| Studies (psyllium) | Trials (psyllium) | Recent Studies (post-2010) (psyllium) | Studies (loperamide) | Trials (loperamide) | Recent Studies (post-2010) (loperamide) |
|---|---|---|---|---|---|
| 731 | 177 | 216 | 1,358 | 196 | 488 |
| Protein | Taxonomy | psyllium (IC50) | loperamide (IC50) |
|---|---|---|---|
| Cocaine esterase | Homo sapiens (human) | 5.7 | |
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3.005 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 2.5 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 9.27 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Histamine H2 receptor | Homo sapiens (human) | 3.081 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.202 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0014 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.337 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.896 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 3.125 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 4.105 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.033 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 0.239 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.628 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madsen, P; Matzen, P; Qvitzau, S | 1 |
| Beasley, TM; Burgio, KL; Goode, PS; Markland, AD; Redden, DT; Richter, HE; Whitehead, WE; Wilcox, CM | 1 |
2 trial(s) available for psyllium and loperamide
| Article | Year |
|---|---|
Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium.
Topics: Adult; Aged; Calcium; Chronic Disease; Clinical Trials as Topic; Diarrhea; Drug Combinations; Female; Humans; Loperamide; Male; Middle Aged; Piperidines; Psyllium; Random Allocation | 1988 |
Loperamide Versus Psyllium Fiber for Treatment of Fecal Incontinence: The Fecal Incontinence Prescription (Rx) Management (FIRM) Randomized Clinical Trial.
Topics: Aged; Antidiarrheals; Cathartics; Constipation; Double-Blind Method; Drug Administration Schedule; Fecal Incontinence; Female; Humans; Loperamide; Male; Middle Aged; Psyllium; Quality of Life; Symptom Assessment; Treatment Outcome | 2015 |
1 other study(ies) available for psyllium and loperamide
| Article | Year |
|---|---|
Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Topics: Acupuncture Therapy; Antidepressive Agents, Tricyclic; Carbolines; Clinical Trials as Topic; Constipation; Diarrhea; Diet Therapy; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Laxatives; Loperamide; Palliative Care; Parasympatholytics; Probiotics; Psychotherapy; Psyllium; Randomized Controlled Trials as Topic | 2009 |